Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...

The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through ...

The new light-rail train, linking Queens and Brooklyn, would signal a shift in the city’s center of gravity, toward one less tethered to the office towers of Midtown.

Tired of Botox and fillers that don’t deliver? Xeomin is emerging as a safer, cleaner neurotoxin that’s redefining non-surgical nose contouring.

This is Neo, the humanoid robot. It's billed as a personal assistant you can talk to and eventually rely on to take care of everyday tasks, such as loading the dishwasher and folding laundry. Neo ...

FDA feedback supports BiomX’s plan to advance its phage-based therapy into DFI as the next clinical indication, following the Company’s previous Phase 2 study of BX211, a phage product for the ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first ...

It’s official: “Six Seven” Just earned the title of Dictionary.com’s 2025 Word of the Year. If you’re still scratching your head about what it actually means, don’t worry. The TODAY.com team is here ...

Arizona stands out in so many ways. It’s uniquely hot and uniquely dry. The saguaro cactus grows nowhere else in the country. And, unlike our out-of-state friends and family who must grapple with time ...